SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-069362
Filing Date
2009-03-31
Accepted
2009-03-31 16:10:16
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 847075
2 AMENDED AND RESTATED SENIOR MANAGEMENT EMPLOYMENT AGREEMENT dex102.htm EX-10.2 55826
3 FIFTH LEASE AMENDMENT dex1015a.htm EX-10.15(A) 38169
4 SUBSIDIARIES OF TARGETED GENETICS CORPORATION dex211.htm EX-21.1 1983
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1903
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 5950
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 5998
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 2955
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3006
  Complete submission text file 0001193125-09-069362.txt   964300
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23930 | Film No.: 09719017
SIC: 2836 Biological Products, (No Diagnostic Substances)